Real-time polymerase chain reaction and culture in the diagnosis of invasive group B streptococcal disease in infants: a retrospective study
- 397 Downloads
Group B streptococcus (GBS) is a leading cause of invasive disease in infants. Accurate and rapid diagnosis is crucial to reduce morbidity and mortality. Real-time polymerase chain reaction (PCR) targeting the dltR gene was utilised for the direct detection of GBS DNA in blood and cerebrospinal fluid (CSF) from infants at an Irish maternity hospital. A retrospective review of laboratory and patient records during the period 2011–2013 was performed in order to evaluate PCR and culture for the diagnosis of invasive GBS disease. A total of 3570 blood and 189 CSF samples from 3510 infants had corresponding culture and PCR results. Culture and PCR exhibited concordance in 3526 GBS-negative samples and 13 (25 %) GBS-positive samples (n = 53). Six (11 %) and 34 (64 %) GBS-positive samples were positive only in culture or PCR, respectively. Culture and PCR identified more GBS-positive infants (n = 47) than PCR (n = 43) or culture (n = 16) alone. Using culture as the reference standard, the sensitivity, specificity, and positive and negative predictive values for PCR on blood samples were 71.4 %, 99.2 %, 25 % and 99.9 %, and for CSF samples, they were 60 %, 97.8 %, 42.9 % and 98.9 %, respectively. The sensitivity and positive predictive values were improved (blood: 84.6 % and 55 %; CSF: 77.8 % and 100 %, respectively) when maternal risk factors and other laboratory test results were considered. The findings in this study recommend the use of direct GBS real-time PCR for the diagnosis of GBS infection in infants with a clinical suspicion of invasive disease and as a complement to culture, but should be interpreted in the light of other laboratory and clinical findings.
KeywordsPolymerase Chain Reaction Polymerase Chain Reaction Result Polymerase Chain Reaction Test Rotunda Hospital Maternal Risk Factor
The authors would like to thank Dr. Kathryn Harris, Great Ormond Street Hospital for the discussion and for providing details of the sip assay in advance of its publication and Dr. Robert Mulhall, Temple Street Children’s University Hospital for the assistance with the R software. The authors would like to acknowledge the Staff of the Irish Meningococcal and Meningitis Reference Laboratory, Temple Street Children’s University Hospital and Department of Clinical Pathology, Rotunda Hospital, in particular Prof. Philip Mayne and Dr. Melanie Cotter, Department of Biochemistry/Endocrinology and Department of Haematology, Rotunda Hospital, respectively, for the provision of laboratory results.
Conflict of interest
The authors declare that they have no conflict of interest.
- 2.Verani JR, McGee L, Schrag SJ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC) (2010) Prevention of perinatal group B streptococcal disease—revised guidelines from CDC, 2010. MMWR Recomm Rep 59:1–36PubMedGoogle Scholar
- 3.Royal College of Obstetricians and Gynaecologists (RCOG) (2012) The prevention of early-onset neonatal group B streptococcal disease. Green-top guideline no. 36, July 2012Google Scholar
- 4.Di Renzo GC, Melin P, Berardi A, Blennow M, Carbonell-Estrany X, Donzelli GP, Hakansson S, Hod M, Hughes R, Kurtzer M, Poyart C, Shinwell E, Stray-Pedersen B, Wielgos M, El Helali N (2015) Intrapartum GBS screening and antibiotic prophylaxis: a European consensus conference. J Matern Fetal Neonatal Med 28:1–17. doi: 10.3109/14767058.2014.934804 CrossRefGoogle Scholar
- 6.Health Protection Surveillance Centre (HPSC) (2014) Report on invasive group B streptococcal infections in Ireland, quarters 1–4 2014. Available online at: http://www.hpsc.ie/A-Z/Other/GroupBStreptococcalDisease/EpidemiologicalData/BiannualReports/File,14217,en.pdf. Accessed 15 June 2015
- 15.Tann CJ, Nkurunziza P, Nakakeeto M, Oweka J, Kurinczuk JJ, Were J, Nyombi N, Hughes P, Willey BA, Elliott AM, Robertson NJ, Klein N, Harris KA (2014) Prevalence of bloodstream pathogens is higher in neonatal encephalopathy cases vs. controls using a novel panel of real-time PCR assays. PLoS One 9:e97259. doi: 10.1371/journal.pone.0097259 PubMedCentralCrossRefPubMedGoogle Scholar
- 18.van den Brand M, Peters RP, Catsburg A, Rubenjan A, Broeke FJ, van den Dungen FA, van Weissenbruch MM, van Furth AM, Kõressaar T, Remm M, Savelkoul PH, Bos MP (2014) Development of a multiplex real-time PCR assay for the rapid diagnosis of neonatal late onset sepsis. J Microbiol Methods 106:8–15. doi: 10.1016/j.mimet.2014.07.034 CrossRefPubMedGoogle Scholar
- 22.Wellinghausen N, Wirths B, Franz AR, Karolyi L, Marre R, Reischl U (2004) Algorithm for the identification of bacterial pathogens in positive blood cultures by real-time LightCycler polymerase chain reaction (PCR) with sequence-specific probes. Diagn Microbiol Infect Dis 48:229–241CrossRefPubMedGoogle Scholar
- 28.Caliendo AM, Gilbert DN, Ginocchio CC, Hanson KE, May L, Quinn TC, Tenover FC, Alland D, Blaschke AJ, Bonomo RA, Carroll KC, Ferraro MJ, Hirschhorn LR, Joseph WP, Karchmer T, MacIntyre AT, Reller LB, Jackson AF; Infectious Diseases Society of America (IDSA) (2013) Better tests, better care: improved diagnostics for infectious diseases. Clin Infect Dis 57:S139–S170. doi: 10.1093/cid/cit578 PubMedCentralCrossRefPubMedGoogle Scholar
- 29.National Institute for Health and Clinical Excellence (NICE) (2012) Antibiotics for early-onset neonatal infection: antibiotics for the prevention and treatment of early-onset neonatal infection. NICE clinical guideline 149, August 2012Google Scholar
- 30.Schroeder EA, Petrou S, Balfour G, Edamma O, Heath PT; Health Protection Agency Group B Streptococcus Working Group (2009) The economic costs of Group B Streptococcus (GBS) disease: prospective cohort study of infants with GBS disease in England. Eur J Health Econ 10:275–285CrossRefPubMedGoogle Scholar
- 32.Peters RP, de Boer RF, Schuurman T, Gierveld S, Kooistra-Smid M, van Agtmael MA, Vandenbroucke-Grauls CM, Persoons MC, Savelkoul PH (2009) Streptococcus pneumoniae DNA load in blood as a marker of infection in patients with community-acquired pneumonia. J Clin Microbiol 47:3308–3312. doi: 10.1128/JCM.01071-09 PubMedCentralCrossRefPubMedGoogle Scholar